Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogen (NEOG) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Neogen (NEOG) over the last 16 years, with Q4 2025 value amounting to $11.7 million.

  • Neogen's Capital Expenditures fell 3198.69% to $11.7 million in Q4 2025 from the same period last year, while for Nov 2025 it was $84.7 million, marking a year-over-year decrease of 2437.28%. This contributed to the annual value of $104.6 million for FY2025, which is 612.63% down from last year.
  • As of Q4 2025, Neogen's Capital Expenditures stood at $11.7 million, which was down 3198.69% from $24.0 million recorded in Q3 2025.
  • In the past 5 years, Neogen's Capital Expenditures registered a high of $38.4 million during Q3 2024, and its lowest value of $1.3 million during Q3 2021.
  • In the last 5 years, Neogen's Capital Expenditures had a median value of $15.6 million in 2023 and averaged $17.9 million.
  • In the last 5 years, Neogen's Capital Expenditures tumbled by 6951.51% in 2021 and then soared by 90355.21% in 2022.
  • Over the past 5 years, Neogen's Capital Expenditures (Quarter) stood at $3.9 million in 2021, then skyrocketed by 207.26% to $12.1 million in 2022, then skyrocketed by 101.69% to $24.4 million in 2023, then decreased by 29.73% to $17.2 million in 2024, then plummeted by 31.99% to $11.7 million in 2025.
  • Its Capital Expenditures was $11.7 million in Q4 2025, compared to $24.0 million in Q3 2025 and $16.1 million in Q2 2025.